These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6693051

  • 1. The prognostic significance of adenomyosis in endometrial carcinoma.
    Hall JB, Young RH, Nelson JH.
    Gynecol Oncol; 1984 Jan; 17(1):32-40. PubMed ID: 6693051
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
    Demopoulos RI, Dubin N, Noumoff J, Blaustein A, Sommers GM.
    Obstet Gynecol; 1986 Aug; 68(2):245-50. PubMed ID: 3737041
    [Abstract] [Full Text] [Related]

  • 3. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases.
    Jacques SM, Lawrence WD.
    Gynecol Oncol; 1990 Jun; 37(3):401-7. PubMed ID: 2351325
    [Abstract] [Full Text] [Related]

  • 4. Adenoacanthoma and mixed adenosquamous carcinoma of the endometrium. A clinicopathologic study.
    Silverberg SG, Bolin MG, DeGiorgi LS.
    Cancer; 1972 Nov; 30(5):1307-14. PubMed ID: 5083064
    [No Abstract] [Full Text] [Related]

  • 5. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
    Carcangiu ML, Chambers JT.
    Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
    [Abstract] [Full Text] [Related]

  • 6. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus.
    Ambros RA, Kurman RJ.
    Cancer; 1992 Mar 15; 69(6):1424-31. PubMed ID: 1371712
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC, Muir IM, Alexander AI, Cauchi M, Bennett RC, Quinn MA.
    Obstet Gynecol; 1988 Sep 15; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
    Nascimento AF, Hirsch MS, Cviko A, Quade BJ, Nucci MR.
    Mod Pathol; 2003 Jan 15; 16(1):22-7. PubMed ID: 12527709
    [Abstract] [Full Text] [Related]

  • 19. Adenoepidermoid and adenosquamous carcinoma of the uterus. A clinicopathologic study of 118 cases.
    Julian CG, Daikoku NH, Gillespie A.
    Am J Obstet Gynecol; 1977 May 01; 128(1):106-16. PubMed ID: 851156
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.